Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29

Mar 22, 2021 ‐ Mar 24, 2021



Sessions

The Desmoplastic Reaction and Intrahepatic Cholangiocarcinoma Progression: CAFs, Select Molecular Drivers, and Prognostic Implications

Mar 22, 2021 6:00pm ‐ Mar 22, 2021 6:30pm

Speaker(s):

Coffee Break iconCoffee Break

Preview Available

Coffee Break

Mar 22, 2021 6:30pm ‐ Mar 22, 2021 6:40pm


Targeting the Tumor Microenvironment for Cholangiocarcinoma Therapy

Mar 22, 2021 6:40pm ‐ Mar 22, 2021 7:10pm

Speaker(s):

Short Talk: p-Ezrin (Thr567) Synergizes with Akt Signaling to Accelerate Yap Mediated Cholangiocarcinogenesis but Correlates with a Favorable Prognosis in Human Intrahepatic Cholangiocarcinoma(ICC) Patients

Mar 22, 2021 7:10pm ‐ Mar 22, 2021 7:25pm

Speaker(s):

Short Talk: SQSTM1/p62 Inhibits whereas Nrf2 Promotes Tumorigenesis by Inducing Cell Population Remodeling and Metabolic Reprograming in Mouse Livers with mTORC1 Activation and Defective Autophagy

Mar 22, 2021 7:25pm ‐ Mar 22, 2021 7:40pm

Speaker(s):

Short Talk: Requirement of Hippo Signaling Cascade during AXIN1 Mutation Driven Hepatocarcinogenesis

Mar 22, 2021 7:40pm ‐ Mar 22, 2021 7:55pm

Speaker(s):

Short Talk: Long Non-Coding RNA NIHCOLE Promotes the DNA Damage Repair of Hepatocellular Carcinoma Cells

Mar 22, 2021 7:55pm ‐ Mar 22, 2021 8:10pm

Speaker(s):

Hepatobiliary Cancer Biomarkers and Molecular Subtypes

Mar 23, 2021 10:00am ‐ Mar 23, 2021 1:10pm

Co-Chair(s):

Liver Cancer Risk-Predictive Molecular Biomarkers Specific to Clinico-Epidemiological Contexts

Mar 23, 2021 10:00am ‐ Mar 23, 2021 10:30am

Speaker(s):

Liquid Biopsy in Hepatobiliary Cancers

Mar 23, 2021 10:30am ‐ Mar 23, 2021 11:00am

Speaker(s):